SCHEMBL2303013

SCHEMBL2303013

CC(N)=NOC(=O)C1CC1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.41
NPC1 O15118 3/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
ATM Q13315 1/20 0.40
RBBP9 O75884 1/20 0.40
PKM P14618 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
LMNA P02545 1/20 0.36
ALDH1A1 P00352 3/20 0.34
POLB P06746 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MAPT P10636 1/20 0.33
MIF P14174 2/20 0.32
NOS3 P29474 1/20 0.32
NOS2 P35228 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3154358 0.85 RAB9A (0.39) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL8970166 0.84 RBBP9 (0.41) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL14370800 0.74 RBBP9 (0.51) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL19462062 0.72 ALDH1A1 (0.40) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL19476974 0.72 ALDH1A1 (0.40) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL17464829 0.71 MMP2 (0.36) NOS3NOS2
SCHEMBL12922726 0.71 NOS2 (0.44) NOS3NOS2
SCHEMBL12328526 0.71 RBBP9 (0.49) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL9507310 0.70
SCHEMBL11682856 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2350090-A2 SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS Xenon Pharmaceuticals Inc. (CA) 2011-08-03 EP disclosed
WO-2010045251-A2 SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS, INC. (CA) 2010-04-22 WO disclosed